-
EP4176902
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4176902
| EP4176902 - ORAL PHARMACEUTICAL COMPOSITION AND METHOD FOR PRODUCING SAME [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 07.04.2023 Database last updated on 22.08.2024 | |
| Former | The international publication has been made Status updated on 07.01.2022 | Most recent event Tooltip | 13.07.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states Artham Therapeutics Inc. 24-8, Yamashita-cho, Naka-ku Yokohama-shi Kanagawa 231-0023 / JP | [2023/19] | Inventor(s) | 01 /
TANAKA, Akira Yokohama-shi, Kanagawa 231-0023 / JP | 02 /
FUNATANI, Chiaki Saitama-shi, Saitama 331-0046 / JP | 03 /
KURA, Kenichi Saitama-shi, Saitama 331-0046 / JP | 04 /
KIMURA, Naoki Saitama-shi, Saitama 331-0046 / JP | [2023/19] | Representative(s) | Jones, Nicholas Andrew Withers & Rogers LLP 2 London Bridge London SE1 9RA / GB | [2023/19] | Application number, filing date | 21834289.7 | 01.07.2021 | [2023/19] | WO2021JP25019 | Priority number, date | JP20200114978 | 02.07.2020 Original published format: JP 2020114978 | JP20210011901 | 28.01.2021 Original published format: JP 2021011901 | [2023/19] | Filing language | JA | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2022004859 | Date: | 06.01.2022 | Language: | JA | [2022/01] | Type: | A1 Application with search report | No.: | EP4176902 | Date: | 10.05.2023 | Language: | EN | [2023/19] | Search report(s) | International search report - published on: | JP | 06.01.2022 | (Supplementary) European search report - dispatched on: | EP | 28.06.2024 | Classification | IPC: | A61K9/00, A61K9/16, A61K31/4439, A61K31/496, A61K31/5377, A61K31/517, A61K31/519, A61K31/553, A61P9/00, A61P35/00 | [2024/31] | CPC: |
A61P9/00 (EP);
A61K31/437 (US);
A61K31/4439 (EP);
A61K31/496 (EP);
A61K31/517 (EP);
A61K31/519 (EP);
A61K31/5377 (EP);
A61K31/553 (EP);
A61K47/02 (US);
A61K47/12 (US);
A61K47/56 (US);
A61K9/0056 (US);
A61K9/0095 (EP);
A61K9/1629 (US);
A61K9/1635 (EP);
|
| Former IPC [2023/19] | A61K47/32, A61K9/10, A61K9/16, A61K31/4439, A61K31/496, A61K31/517, A61K31/519, A61K31/5377, A61K31/553, A61K45/00, A61K47/02, A61K47/04, A61K47/12, A61K47/18, A61K47/22, A61K47/34, A61K47/38, A61P9/00, A61P35/00 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/19] | Title | German: | ORALE PHARMAZEUTISCHE ZUSAMMENSETZUNG UND VERFAHREN ZUR HERSTELLUNG DAVON | [2023/19] | English: | ORAL PHARMACEUTICAL COMPOSITION AND METHOD FOR PRODUCING SAME | [2023/19] | French: | COMPOSITION PHARMACEUTIQUE ORALE ET SON PROCÉDÉ DE FABRICATION | [2023/19] | Entry into regional phase | 13.12.2022 | Translation filed | 13.12.2022 | National basic fee paid | 13.12.2022 | Search fee paid | 13.12.2022 | Designation fee(s) paid | 13.12.2022 | Examination fee paid | Examination procedure | 13.12.2022 | Examination requested [2023/19] | 28.06.2023 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 17.07.2023 | Renewal fee patent year 03 | 12.07.2024 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [Y]WO2019075108 (METCALF ANDREW T [US], et al); | International search | [XY]JP2004518676 ; | [XY]JP2009504796 ; | [XY]JP2009504795 ; | [Y]WO2016175230 (ASTELLAS PHARMA INC [JP]); | [XY]JP2017002034 (PFIZER); | [XY]JP2019510059 ; |